Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
- Conditions
- Hypertriglyceridemia
- First Posted Date
- 2004-03-25
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Medical Research Laboratories International
- Target Recruit Count
- 50
- Registration Number
- NCT00080132
- Locations
- πΊπΈ
Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio, United States
πΊπΈThe Methodist Hospital, Houston, Texas, United States
π³π±Academic Medical Center Amsterdam, Amsterdam, Netherlands
Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy
- Conditions
- Familial Hypercholesterolemia
- First Posted Date
- 2004-03-18
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Medical Research Laboratories International
- Target Recruit Count
- 60
- Registration Number
- NCT00079846
- Locations
- πΊπΈ
Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio, United States
π¨π¦Lipid Clinic and Community Genomic Center, Complexe Hospitalier de la Sagamie, Chicoutimi, Quebec, Canada
π¨π¦Lipid Research Center, CHUL du CHUQ, Sainte-Foy, Quebec, Canada
Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
- Conditions
- Familial Hypercholesterolemia
- First Posted Date
- 2004-03-18
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Medical Research Laboratories International
- Target Recruit Count
- 120
- Registration Number
- NCT00079859
- Locations
- πΊπΈ
Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio, United States
π³π±Andromed Leiden, Leiden, Netherlands
π³π±Andromed Rotterdam, Rotterdam, Netherlands